Channel Therapeutics Corporation (CHRO)
NYSEAMERICAN: CHRO · Real-Time Price · USD
1.420
-0.170 (-10.69%)
Mar 31, 2025, 9:30 AM EST - Market open

Channel Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
94----
Enterprise Value
115----
Last Close Price
1.590.64----
PB Ratio
-3.53-1.42----
Debt / Equity Ratio
-0.80-0.80-0.20-0.15-0.30-0.07
Quick Ratio
0.130.130.020.02--
Current Ratio
0.340.340.020.02-0.02
Return on Assets (ROA)
-645.79%-645.79%-5663.30%---
Earnings Yield
-83.00%-205.89%----
Buyback Yield / Dilution
-336.69%-336.69%-193.25%---
Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q